Tenderwize
Back to tender search

Open house Rituximab discount agreements

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Oct 05, 2026 · 50 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rituximab, ATC L01FA01

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated value or volume commitment; participation does not guarantee any sales or revenue.

Agreements may be superseded by a nationwide or region-wide competitive discount contract for the same active substance...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Nov 2026
  • Supply of pharmaceutical products containing Rituximab (ATC L01FA01) to AOK Bayern
  • Non-exclusive discount agreements under §130a Abs. 8 SGB V
Show full summary

Open-house model for non-exclusive discount agreements for the active substance Rituximab (ATC L01FA01) with AOK Bayern. This is not a public procurement procedure but a voluntary agreement under §130a Abs. 8 SGB V. All interested pharmaceutical companies meeting eligibility can join. No estimated value or award criteria provided as all eligible participants are accepted. Contract duration from 01.12.2024 to 30.11.2026, with possible earlier termination if a competing nationwide discount agreement takes effect.

Risks

No estimated value or volume commitment; participation does not guarantee any sales or revenue.

Agreements may be superseded by a nationwide or region-wide competitive discount contract for the same active substance...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company (pharmazeutischer Unternehmer)
  • Provide signed contract and annex defining covered medicines

Administrative

  • Submit signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit)

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Rituximab discount agreements

Open-house model for non-exclusive discount agreements for Rituximab. The AOK Bayern offers identical, non-negotiable contracts to all interested pharmaceutical companies that meet the eligibility criteria.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Nov 2024 - Nov 2026

Category

Pharmaceutical products

Deadline

Deadline Oct 05, 2026

Procurement Details

Publication date
16 Oct 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
627573-2024

Documents (2)

Similar tenders